More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

Penthrox submitted for approval in 22 European Countries

Nov 29, 2016 at 1:02 AM EST · Issued by Medical Developments International Limited

Filed with ASX · Nov 29, 2016 at 1:02 AM EST · 3 pages · English

On 6ix: 6ix.com/news/penthrox-submitted-for-approval-in-22-european-countries

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

  • POST TRUMP - Business as usual, MVP signs a Respiratory dealNov 13, 2016
  • S&P DJ Indices Announces March Quarterly ReviewNov 7, 2016
  • S&P DJ Indices Announces March Quarterly RebalanceNov 6, 2016
  • MVP signs major deal with CSIROOct 27, 2016
  • MVP signs Licensing Agreement for Penthrox in CandaSep 12, 2016

Later from Medical Developments International

  • Penthrox approved for sale in TaiwanDec 7, 2016
  • Penthrox European UpdateFeb 6, 2017
  • Penthrox Launched in France and Belgium and first salesFeb 7, 2017
  • Penthrox Second order for UK and IrelandMar 1, 2017
  • MVPs Respiratory Devices in all Walmart stores in the USAApr 9, 2017
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer